ATRC - AtriCure, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 22.3

Open

$ 22.00

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 21.43 - $ 22.32

52 Week Range

$ 20.19 - $ 59.61

Volume

899,399

Average Volume

Market Cap

1.04B

Beta (5Y Monthly)

$ 1.36

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-16-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	07-26-2023	06-30-2023	10-Q
5	05-03-2023	03-31-2023	10-Q
6	02-22-2023	12-31-2022	10-K
7	11-02-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	02-17-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	04-28-2021	03-31-2021	10-Q
14	02-26-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	07-29-2020	06-30-2020	10-Q
17	04-30-2020	03-31-2020	10-Q
18	02-24-2020	12-31-2019	10-K
19	10-31-2019	09-30-2019	10-Q
20	07-31-2019	06-30-2019	10-Q
21	04-26-2019	03-31-2019	10-Q
22	03-01-2019	12-31-2018	10-K
23	11-02-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	04-27-2018	03-31-2018	10-Q
26	02-28-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	07-28-2017	06-30-2017	10-Q
29	05-05-2017	03-31-2017	10-Q
30	03-08-2017	12-31-2016	10-K
31	10-28-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	04-29-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	10-30-2015	09-30-2015	10-Q
36	07-31-2015	06-30-2015	10-Q
37	05-01-2015	03-31-2015	10-Q
38	03-02-2015	12-31-2014	10-K
39	10-31-2014	09-30-2014	10-Q
40	07-30-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on AtriCur...
05/02/2024 19:10:40

Canaccord Genuity analyst William Plovanic maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $57 ...

JP Morgan Maintains Overweight on AtriCure...
05/02/2024 16:09:31

JP Morgan analyst Robbie Marcus maintains AtriCure (NASDAQ:ATRC) with a Overweight and lowers the price target from $42 to $34.

Cracking The Code: Understanding Analyst R...
05/02/2024 12:01:21

Needham Maintains Buy on AtriCure, Lowers ...
05/02/2024 09:45:28

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $46 to $40.

ArtiCure Sees FY24 Adj. EPS $(0.82)-$(0.74...
05/01/2024 20:38:29

AtriCure Q1 2024 Adj EPS $(0.25) Misses $(...
05/01/2024 20:21:50

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by...

Oppenheimer Upgrades AtriCure to Outperfor...
04/23/2024 11:40:45

Oppenheimer analyst Suraj Kalia upgrades AtriCure (NASDAQ:ATRC) from Perform to Outperform and announces $32 price target.

AtriCure Launched cryoSPHERE+ Cryoablation...
04/18/2024 12:08:32

Key Takeaways From AtriCure Analyst Ratings
04/10/2024 12:01:20

Needham Reiterates Buy on AtriCure, Mainta...
04/10/2024 09:34:11

Needham analyst Mike Matson reiterates AtriCure (NASDAQ:ATRC) with a Buy and maintains $46 price target.

Coinbase To Rally Around 45%? Here Are 10 ...
02/16/2024 13:30:24

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Cracking The Code: Understanding Analyst R...
02/16/2024 12:00:13

Needham Maintains Buy on AtriCure, Raises ...
02/16/2024 10:41:21

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $44 to $46.

Recap: AtriCure Q4 Earnings
02/15/2024 21:05:14

AtriCure Q4 2023 Adj EPS $(0.21) Beats $(0...
02/15/2024 21:03:40

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8...

Earnings Scheduled For February 15, 2024
02/15/2024 10:17:01

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

AtriCure's Earnings: A Preview
02/14/2024 15:01:57

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/18/2024 13:05:59

Key Takeaways From AtriCure Analyst Ratings
01/04/2024 12:00:54

Needham Maintains Buy on AtriCure, Lowers ...
01/04/2024 11:27:36

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $49 to $44.